Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analyses
The Journal of Allergy and Clinical Immunology, 05/31/2011
Evidence Based Medicine
Matricardi PM et al.– The data provide indirect but consistent evidence that subcutaneous immunotherapy (SCIT) is at least as potent as pharmacotherapy in controlling the symptoms of seasonal allergic rhinitis (SAR) as early as the first season of treatment.



